Antecedentes de vacunación en pacientes con COVID-19

A. S. Alvarez Villaseñor, José Luis Ahuja Navarro, Saúl Nevarez Jiménez, Josefina Mérit Velázquez Morales, Gustavo Alberto Urbiola Rodriguez, Diana Erika Gómez Campos, Gustavo Armando Granados De la Ros
{"title":"Antecedentes de vacunación en pacientes con COVID-19","authors":"A. S. Alvarez Villaseñor, José Luis Ahuja Navarro, Saúl Nevarez Jiménez, Josefina Mérit Velázquez Morales, Gustavo Alberto Urbiola Rodriguez, Diana Erika Gómez Campos, Gustavo Armando Granados De la Ros","doi":"10.21840/siic/170746","DOIUrl":null,"url":null,"abstract":"Introduction: Vaccines against COVID-19 are effective. However, a percentage of people with a complete vaccination scheme are at risk of contracting and becoming ill from COVID-19. These cases are known as \"vaccinated cases of infection\". Objective: To identify the clinical characteristics of patients with SARS-CoV-2 infection with a history of vaccination for COVID-19. Methods: Retrospective cohort study in 271 vaccinated and positive patients who attended medical units in Baja California Sur, with or without a complete scheme and registered in SINOLAVE. Clinical characteristics, management, sequelae and mortality were analyzed. Descriptive statistics and association measures were used. Authorized by the ethics and research committees. Results: Age 48.5 ± 12.1 years, 19.5% met the definition of infection in vaccinated, 93% with outpatient management, 3.7% mortality, the most frequent comorbidity: diabetes / hypertension. 92% of the cases vaccinated with Cansino had COVID, followed by Pfizer with 26%. There is a higher risk of hospitalization and mortality in patients with an incomplete scheme. Conclusions: The vaccines are effective, most of the cases were ambulatory. Patients vaccinated with Cansino showed a higher COVID infection, the reinforcement of this vaccine could reduce the disease in patients already vaccinated. Of the patients who died, the majority did not have a complete vaccination schedule.","PeriodicalId":375713,"journal":{"name":"Salud(i)ciencia (Impresa)","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Salud(i)ciencia (Impresa)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21840/siic/170746","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction: Vaccines against COVID-19 are effective. However, a percentage of people with a complete vaccination scheme are at risk of contracting and becoming ill from COVID-19. These cases are known as "vaccinated cases of infection". Objective: To identify the clinical characteristics of patients with SARS-CoV-2 infection with a history of vaccination for COVID-19. Methods: Retrospective cohort study in 271 vaccinated and positive patients who attended medical units in Baja California Sur, with or without a complete scheme and registered in SINOLAVE. Clinical characteristics, management, sequelae and mortality were analyzed. Descriptive statistics and association measures were used. Authorized by the ethics and research committees. Results: Age 48.5 ± 12.1 years, 19.5% met the definition of infection in vaccinated, 93% with outpatient management, 3.7% mortality, the most frequent comorbidity: diabetes / hypertension. 92% of the cases vaccinated with Cansino had COVID, followed by Pfizer with 26%. There is a higher risk of hospitalization and mortality in patients with an incomplete scheme. Conclusions: The vaccines are effective, most of the cases were ambulatory. Patients vaccinated with Cansino showed a higher COVID infection, the reinforcement of this vaccine could reduce the disease in patients already vaccinated. Of the patients who died, the majority did not have a complete vaccination schedule.
COVID-19患者的疫苗接种史
导言:COVID-19疫苗是有效的。然而,在接种了完整疫苗计划的人群中,有一定比例的人面临感染COVID-19并因此患病的风险。这些病例被称为“接种疫苗感染病例”。目的:了解有COVID-19疫苗接种史的SARS-CoV-2感染患者的临床特征。方法:回顾性队列研究,在下加利福尼亚州南部医疗单位就诊的271例接种疫苗和阳性患者,有或没有完整的方案,并在SINOLAVE注册。分析其临床特点、处理、后遗症及死亡率。采用描述性统计和关联测量。经伦理委员会和研究委员会授权。结果:年龄48.5±12.1岁,接种者符合感染定义的19.5%,门诊就诊93%,病死率3.7%,最常见的合并症为糖尿病/高血压。接种Cansino疫苗的患者中有92%感染了COVID,其次是辉瑞,占26%。方案不完整的患者有较高的住院和死亡风险。结论:疫苗接种效果良好,大部分病例为门诊病例。接种Cansino疫苗的患者COVID感染率较高,强化接种Cansino疫苗可降低已接种Cansino疫苗的患者的感染率。在死亡的患者中,大多数没有完整的疫苗接种计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信